From: Molecular signatures define two main classes of meningiomas
 | SF4271 | SF4287 | SF4316 | SF4465 | SF4881 | SF4886 | SF4894 | SF4931 | SF3072 | SF3118 | SF3363 | SF3411 | SF4151 | SF2176 | SF3622 | SF2841 | SF3476 | SF3595 | SF3693 | SF3938 | SF4005 | SF4290 | SF4457 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grade | BENIGN (GRADE 1) | ATYPICAL (GRADE 2) | MALIGNANT (GRADE 3) | ||||||||||||||||||||
Molecular Subgroup | LOW-PROLIFERATIVE | * | HIGH-PROLIFERATIVE | ||||||||||||||||||||
Embolized | No | Y | Y | No | No | No | No | Y | No | Y | No | Y | No | No | No | Y | Y | No | N | Y | Y | Y | No |
Histological Subtype | M | T | M | M | Fi | T | T | T | Â | Â | Â | Â | Â | CC | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Mitotic Index | N | N | N | N | N | E/F | E/F | N | N | N | N | N | E/F | N | E/F | E | E/F | E | E | E | E | E | E |
Increased Cellularity | E/F | N | N | N | N | N | E/F | N | N | E/F | E/F | E | E/F | E | E | E | E | E | E | E | E | E | E |
Nuclear/Cytoplasmic Ratio | E/F | N | E/F | N | N | E/F | E/F | N | E | E | E | E | N | E/F | E/F | E | F | E | E | E | E | E | E |
Prominent Nucleoli | E/F | N | E/F | N | N | E/F | E/F | N | E | E | E | E | N | E/F | E/F | E | F | E | E | E | E | E | E |
Cellular Pattern Loss | E/F | N | N | N | N | N | E/F | N | N | E/F | E/F | E | E/F | E | E | E | E/F | E | E | E | E | E | E |
Necrosis | E/F | E/F | E/F | N | N | N | N | N | N | N | N | E | N | N | E | E | E | E | E/F | E | E | E | E |
Brain Invasion | Â | Â | Â | Â | Â | Â | Â | Â | Y | Â | Â | Â | Â | Â | Â | Y | Â | Â | Â | Â | Y | Â | Â |
MIB-1 | 1.5 | 1.6 | 2.0 | 0.9 | 0.8 | 0.1 | 1.3 | 1.9 | 5.9 | 4.2 | 3.7 | 7.0 | 7.0 | 7.7 | 8.5 | 10.9 | 11.3 | 17.5 | 20.3 | 16.9 | 7.5 | 7.5 | 23.3 |